Carregant...
Tocilizumab for thyroid eye disease
BACKGROUND: Thyroid eye disease (TED) is an autoimmune disorder that constitutes a major clinical and therapeutic challenge. Current treatment options for moderate‐to‐severe TED include immunotherapy, orbital radiotherapy and decompression surgery. Limited drugs of proven efficacy are available for...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2018
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517231/ https://ncbi.nlm.nih.gov/pubmed/30480323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012984.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|